Agonists of 5-HT3 have been shown to be effective in treating IBS associated with diarrhea, while 5-HT4 agonists have proven effective in treating IBS associated with constipation and chronic constipation [53]. The gene discussed is HTR3A; the disease is Chronic constipation.